Pacer Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Pacer Advisors, Inc.
- $38.6 Billion
- Q1 2024
A detailed history of Pacer Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,494,914 shares of HRMY stock, worth $75.3 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
2,494,914
Previous 1,224,910
103.68%
Holding current value
$75.3 Million
Previous $39.6 Million
111.76%
% of portfolio
0.22%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
213Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$338 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$179 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$109 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$78.6 Million11.71% of portfolio
-
State Street Corp Boston, MA1.3MShares$39.1 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.78B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...